Health | WAMU 88.5 - American University Radio

Health

RSS Feed
NPR

Why Is This Year's Flu Season Off To A Slow Start?

Researchers say it might be because of the more temperate weather, or the nature of the flu strains now in circulation. It's been around for a year or two so a lot of people have already been exposed, and have built up a natural immunity.
WAMU 88.5

Amendment To Virginia Ultrasound Bill Passed

After a national outcry over a Virginia bill that would have requirde that women to have invasive ultrasounds prior to an abortion, legislators in Virginia's House struck the controversial provision.

NPR

A Puff Of Controversy Over Inhalable Caffeine

The U.S. Food and Drug Administration has questions about the safety and legality of AeroShot, the inhalable caffeine product released last month. So does the American Academy of Pediatrics.
NPR

High Court Punts On California Medicaid Ruling

California patients and doctors had sued to block the state's decision to cut Medicaid payment rates. But instead of ruling on the matter, the U.S. Supreme Court sent the case back to a lower court, saying "changed circumstances" in the case warrant a different process for deciding it.
NPR

Diet Drug Qnexa Gets Thumbs-Up From FDA Panel

In a reversal, a panel of experts is advising the Food and Drug Administration to approve Qnexa, a weight-loss pill, that was rejected in 2010. The potential benefits for overweight people exceed the risks, such as birth defects and increased heart rates, the panel determined.
NPR

FDA Recommends Approval For New Obesity Drug

Advisers to the Food and Drug Administration have recommended approval of a new obesity drug called Qnexa. The advisory panel had rejected the drug two years ago due to concerns about possible birth defects and heart problems. But new studies presented by the drug's maker convinced the panel that the benefits of the drug outweighed its risks. The panel did recommend, however, the company that makes the drug conduct a follow-up study to better assess the drug's risk to the heart. The FDA usually follows the advice of its advisers.

Pages